Literature DB >> 17624738

Absence of Smad3 confers radioprotection through modulation of ERK-MAPK in primary dermal fibroblasts.

Praveen R Arany1, Kathleen C Flanders, William DeGraff, John Cook, James B Mitchell, Anita B Roberts.   

Abstract

BACKGROUND: Transforming growth factor-beta1 (TGF-beta1), a key biological mediator following ionizing radiation, plays a role in a complex tissue reaction involved in local radiation-induced pathological damage. Knocking out Smad3 (S3KO), a downstream signaling intermediate in the TGF-beta pathway, in mice protects their skin from radiation damage as demonstrated by decreased epithelial acanthosis and dermal fibrosis as compared to Smad3 wild-type (S3WT) mice.
OBJECTIVE: The present study was designed to investigate the molecular mechanisms contributing to increased radioprotection in the absence of Smad3.
METHODS: Primary dermal fibroblasts derived from S3WT and KO mice were exposed to 5Gy ionizing radiation in vitro. Western blot analyses, immunocytochemistry, and reporter transfections were used to dissect the radiation-induced events.
RESULTS: There was increased phosphorylation of ERK-MAPK, p53 and H2A.X in S3KO compared to the S3WT fibroblasts, implicating them in a key signaling cascade in response of these cells to radiation. Pro-fibrotic gene expression was decreased in S3KO fibroblasts post-irradiation.
CONCLUSION: The absence of Smad3 may decrease radio-responsiveness by increasing activation of DNA damage sensing mechanisms and decreasing induction of pro-fibrotic genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624738      PMCID: PMC2016790          DOI: 10.1016/j.jdermsci.2007.05.012

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  33 in total

1.  Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Authors:  Kathleen C Flanders; Christopher D Major; Alidad Arabshahi; Ekinadese E Aburime; Miya H Okada; Makiko Fujii; Timothy D Blalock; Gregory S Schultz; Anastasia Sowers; Mario A Anzano; James B Mitchell; Angelo Russo; Anita B Roberts
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 2.  Lateral signaling enhances TGF-beta response complexity.

Authors:  Stacey DaCosta Byfield; Anita B Roberts
Journal:  Trends Cell Biol       Date:  2004-03       Impact factor: 20.808

3.  Recruitment of p300/CBP in p53-dependent signal pathways.

Authors:  M L Avantaggiati; V Ogryzko; K Gardner; A Giordano; A S Levine; K Kelly
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

4.  Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and "non-fibrosing" mice during the latent period and early phase after irradiation.

Authors:  A J Franko; J Sharplin; A Ghahary; M H Barcellos-Hoff
Journal:  Radiat Res       Date:  1997-02       Impact factor: 2.841

5.  Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation.

Authors:  E J Ehrhart; P Segarini; M L Tsang; A G Carroll; M H Barcellos-Hoff
Journal:  FASEB J       Date:  1997-10       Impact factor: 5.191

6.  Phosphorylation of p53 serine 15 increases interaction with CBP.

Authors:  P F Lambert; F Kashanchi; M F Radonovich; R Shiekhattar; J N Brady
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

7.  DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

Authors:  S Y Shieh; M Ikeda; Y Taya; C Prives
Journal:  Cell       Date:  1997-10-31       Impact factor: 41.582

8.  TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.

Authors:  Neil A Bhowmick; Anna Chytil; David Plieth; Agnieszka E Gorska; Nancy Dumont; Scott Shappell; M Kay Washington; Eric G Neilson; Harold L Moses
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

9.  Changes in plasma TGF beta levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis.

Authors:  M S Anscher; T Murase; D M Prescott; L B Marks; H Reisenbichler; G C Bentel; D Spencer; G Sherouse; R L Jirtle
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

10.  Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy.

Authors:  J Wang; H Zheng; C C Sung; K K Richter; M Hauer-Jensen
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

View more
  7 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

Review 2.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

3.  Laser-activated transforming growth factor-β1 induces human β-defensin 2: implications for laser therapies for periodontitis and peri-implantitis.

Authors:  E Tang; I Khan; S Andreana; P R Arany
Journal:  J Periodontal Res       Date:  2016-07-11       Impact factor: 4.419

4.  Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis.

Authors:  Tomer Avraham; Alan Yan; Jamie C Zampell; Sanjay V Daluvoy; Adriana Haimovitz-Friedman; Andrew P Cordeiro; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-02       Impact factor: 4.249

5.  Absence of Smad3 induces neutrophil migration after cutaneous irradiation: possible contribution to subsequent radioprotection.

Authors:  Kathleen C Flanders; Benjamin M Ho; Praveen R Arany; Christina Stuelten; Mizuko Mamura; Miya Okada Paterniti; Anastasia Sowers; James B Mitchell; Anita B Roberts
Journal:  Am J Pathol       Date:  2008-05-23       Impact factor: 4.307

Review 6.  Emerging targets for radioprotection and radiosensitization in radiotherapy.

Authors:  Sumit Kumar; Rajnish Kumar Singh; Ramovatar Meena
Journal:  Tumour Biol       Date:  2016-06-19

7.  Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice.

Authors:  Yanna Nie; Shuyu Li; Yuee Yi; Weilian Su; Xinlou Chai; Dexian Jia; Qian Wang
Journal:  BMC Complement Altern Med       Date:  2014-05-05       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.